Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019

SELL
$41.54 - $47.25 $418,598 - $476,138
-10,077 Closed
0 $0
Q3 2018

Nov 07, 2018

BUY
$46.76 - $51.24 $471,200 - $516,345
10,077 New
10,077 $475,000
Q2 2018

Sep 17, 2018

SELL
$44.29 - $50.42 $681,313 - $775,610
-15,383 Closed
0 $0
Q1 2018

May 08, 2018

BUY
$48.49 - $58.14 $745,921 - $894,367
15,383 New
15,383 $757,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $273B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Strategic Wealth Advisors Group, LLC Portfolio

Follow Strategic Wealth Advisors Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Advisors Group, LLC with notifications on news.